Sfoglia per Autore
Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidences
2022-12-01 Barreca M.; Lang N.; Tarantelli C.; Spriano F.; Barraja P.; Bertoni F.
Development of [1,2]oxazoloisoindoles tubulin polymerization inhibitors: Further chemical modifications and potential therapeutic effects against lymphomas
2022-12-05 Barreca M.; Spano' V.; Rocca R.; Bivacqua R.; Abel A.-C.; Maruca A.; Montalbano A.; Raimondi M.V.; Tarantelli C.; Gaudio E.; Cascione L.; Rinaldi A.; Bai R.; Steinmetz M.O.; Prota A.E.; Alcaro S.; Hamel E.; Bertoni F.; Barraja P.
Insight into non-nucleoside triazole-based systems as viral polymerases inhibitors
2023-03-05 Bivacqua R.; Barreca M.; Spano' V.; Raimondi M.V.; Romeo I.; Alcaro S.; Andrei G.; Barraja P.; Montalbano A.
HSV-1 Glycoprotein D and Its Surface Receptors: Evaluation of Protein–Protein Interaction and Targeting by Triazole-Based Compounds through In Silico Approaches
2023-04-11 Bivacqua R.; Romeo I.; Barreca M.; Barraja P.; Alcaro S.; Montalbano A.
Exploring the anticancer activity and the mechanism of action of pyrrolomycins F obtained by microwave-assisted total synthesis
2023-04-11 Barreca, Marilia; Buttacavoli, Miriam; Di Cara, Gianluca; D'Amico, Cesare; Peri, Emanuela; Spano', Virginia; Li Petri, Giovanna; Barraja, Paola; Raimondi, Maria Valeria; Cancemi, Patrizia; Montalbano, Alessandra
Editorial: Emerging heterocycles as bioactive compounds
2023-04-26 Li Petri, Giovanna; Holl, Ralph; Spano', Virginia; Barreca, Marilia; Sardo, Ignazio; Raimondi, Maria Valeria
Novel tricyclic pyrrolo-quinolines as pharmacological correctors of the mutant CFTR chloride channel
2023-05-10 Renda M.; Barreca M.; Borrelli A.; Spano' V.; Montalbano A.; Raimondi M.V.; Bivacqua R.; Musante I.; Scudieri P.; Guidone D.; Buccirossi M.; Genovese M.; Venturini A.; Bandiera T.; Barraja P.; Galietta L.J.V.
Identification of pyrrolo[3′,4’:3,4]cyclohepta[1,2-d][1,2]oxazoles as promising new candidates for the treatment of lymphomas
2023-06-05 Barreca M.; Spano' V.; Rocca R.; Bivacqua R.; Gualtieri G.; Raimondi M.V.; Gaudio E.; Bortolozzi R.; Manfreda L.; Bai R.; Montalbano A.; Alcaro S.; Hamel E.; Bertoni F.; Viola G.; Barraja P.
The ATR inhibitor elimusertib exhibits anti-lymphoma activity and synergizes with the PI3K inhibitor copanlisib
2023-11-27 Sartori, Giulio; Tarantelli, Chiara; Spriano, Filippo; Gaudio, Eugenio; Cascione, Luciano; Mascia, Michele; Barreca, Marilia; Arribas, Alberto J; Licenziato, Luca; Golino, Gaetanina; Ferragamo, Adele; Pileri, Stefano; Damia, Giovanna; Zucca, Emanuele; Stathis, Anastasios; Politz, Oliver; Wengner, Antje M; Bertoni, Francesco
Advances in developing noncovalent small molecules targeting Keap1
2023-12-01 Barreca, Marilia; Qin, Yuting; Cadot, Marie Elodie Hélène; Barraja, Paola; Bach, Anders
| Data di pubblicazione | Titolo | Autori | Tipologia | Autore(i) | File |
|---|---|---|---|---|---|
| 1-dic-2022 | Antibody-drug conjugates for lymphoma patients: preclinical and clinical evidences | Barreca M.Barraja P. + | 01 - Contributo in rivista::1.09 Review essay (rassegna critica) | Barreca M.; Lang N.; Tarantelli C.; Spriano F.; Barraja P.; Bertoni F. | |
| 5-dic-2022 | Development of [1,2]oxazoloisoindoles tubulin polymerization inhibitors: Further chemical modifications and potential therapeutic effects against lymphomas | Barreca M.Spano' V.Bivacqua R.Montalbano A.Raimondi M. V.Barraja P. + | 01 - Contributo in rivista::1.01 Articolo in rivista | Barreca M.; Spano' V.; Rocca R.; Bivacqua R.; Abel A.-C.; Maruca A.; Montalbano A.; Raimondi M.V.; Tarantelli C.; Gaudio E.; Cascione L.; Rinaldi A.; Bai R.; Steinmetz M.O.; Prota A.E.; Alcaro S.; Hamel E.; Bertoni F.; Barraja P. | |
| 5-mar-2023 | Insight into non-nucleoside triazole-based systems as viral polymerases inhibitors | Bivacqua R.Barreca M.Spano' V.Raimondi M. V.Barraja P.Montalbano A. + | 01 - Contributo in rivista::1.09 Review essay (rassegna critica) | Bivacqua R.; Barreca M.; Spano' V.; Raimondi M.V.; Romeo I.; Alcaro S.; Andrei G.; Barraja P.; Montalbano A. | |
| 11-apr-2023 | HSV-1 Glycoprotein D and Its Surface Receptors: Evaluation of Protein–Protein Interaction and Targeting by Triazole-Based Compounds through In Silico Approaches | Bivacqua R.Barreca M.Barraja P.Montalbano A. + | 01 - Contributo in rivista::1.01 Articolo in rivista | Bivacqua R.; Romeo I.; Barreca M.; Barraja P.; Alcaro S.; Montalbano A. | |
| 11-apr-2023 | Exploring the anticancer activity and the mechanism of action of pyrrolomycins F obtained by microwave-assisted total synthesis | Barreca, MariliaButtacavoli, MiriamDi Cara, GianlucaD'Amico, CesarePeri, EmanuelaSpano', VirginiaBarraja, PaolaRaimondi, Maria ValeriaCancemi, PatriziaMontalbano, Alessandra + | 01 - Contributo in rivista::1.01 Articolo in rivista | Barreca, Marilia; Buttacavoli, Miriam; Di Cara, Gianluca; D'Amico, Cesare; Peri, Emanuela; Spano', Virginia; Li Petri, Giovanna; Barraja, Paola; Raimondi, Maria Valeria; Cancemi, Patrizia; Montalbano, Alessandra | |
| 26-apr-2023 | Editorial: Emerging heterocycles as bioactive compounds | Spano', VirginiaBarreca, MariliaSardo, IgnazioRaimondi, Maria Valeria + | 01 - Contributo in rivista::1.11 Nota o commento | Li Petri, Giovanna; Holl, Ralph; Spano', Virginia; Barreca, Marilia; Sardo, Ignazio; Raimondi, Maria Valeria | |
| 10-mag-2023 | Novel tricyclic pyrrolo-quinolines as pharmacological correctors of the mutant CFTR chloride channel | Barreca M.Borrelli A.Spano' V.Montalbano A.Raimondi M. V.Bivacqua R.Barraja P. + | 01 - Contributo in rivista::1.01 Articolo in rivista | Renda M.; Barreca M.; Borrelli A.; Spano' V.; Montalbano A.; Raimondi M.V.; Bivacqua R.; Musante I.; Scudieri P.; Guidone D.; Buccirossi M.; Genovese M.; Venturini A.; Bandiera T.; Barraja P.; Galietta L.J.V. | |
| 5-giu-2023 | Identification of pyrrolo[3′,4’:3,4]cyclohepta[1,2-d][1,2]oxazoles as promising new candidates for the treatment of lymphomas | Barreca M.Spano' V.Bivacqua R.Raimondi M. V.Montalbano A.Barraja P. + | 01 - Contributo in rivista::1.01 Articolo in rivista | Barreca M.; Spano' V.; Rocca R.; Bivacqua R.; Gualtieri G.; Raimondi M.V.; Gaudio E.; Bortolozzi R.; Manfreda L.; Bai R.; Montalbano A.; Alcaro S.; Hamel E.; Bertoni F.; Viola G.; Barraja P. | |
| 27-nov-2023 | The ATR inhibitor elimusertib exhibits anti-lymphoma activity and synergizes with the PI3K inhibitor copanlisib | Barreca, Marilia + | 01 - Contributo in rivista::1.01 Articolo in rivista | Sartori, Giulio; Tarantelli, Chiara; Spriano, Filippo; Gaudio, Eugenio; Cascione, Luciano; Mascia, Michele; Barreca, Marilia; Arribas, Alberto J; Licenziato, Luca; Golino, Gaetanina; Ferragamo, Adele; Pileri, Stefano; Damia, Giovanna; Zucca, Emanuele; Stathis, Anastasios; Politz, Oliver; Wengner, Antje M; Bertoni, Francesco | |
| 1-dic-2023 | Advances in developing noncovalent small molecules targeting Keap1 | Barreca, MariliaBarraja, Paola + | 01 - Contributo in rivista::1.09 Review essay (rassegna critica) | Barreca, Marilia; Qin, Yuting; Cadot, Marie Elodie Hélène; Barraja, Paola; Bach, Anders |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile